For the Inventor, By the Inventor

Enter assignee name

Leverkusen, Germany

Bayer Healthcare Aktiengesellschaft

USPTO Granted Patents = 77

CIPO Patents = 8

EPO Patents = 1

Forward Citations = 656

Loading Chart...

Loading Chart...

241 inventors (with patents filed for the assignee):

Karl-Heinz Schlemmer (14 out of 120 patents)

Thomas Lampe (10 out of 42 patents)

Joachim Luithle (9 out of 32 patents)

4. Jörg Keldenich (9 out of 41 patents)

5. Johannes-Peter Stasch (8 out of 150 patents)

6. Elisabeth Perzborn (7 out of 101 patents)

7. Erwin Bischoff (7 out of 49 patents)

8. Christoph Methfessel (6 out of 24 patents)

9. Jens Pohlmann (6 out of 19 patents)

10. Elke Stahl (6 out of 29 patents)

11. Christina Erb (5 out of 35 patents)

12. Ulrich Rosentreter (5 out of 48 patents)

13. Mary F Fitzgerald (5 out of 18 patents)

14. Achim Feurer (5 out of 33 patents)

15. Helmut Haning (5 out of 27 patents)

Core Competencies:

Acetic Acid Amides

Biomedical Assays

Pyrimidinone Derivatives

Antibacterial Properties

Neuromedin U2 Receptor

G-Protein Coupled Receptor

Adenylate Cyclase

Dihydropyridinone Derivatives

Hematopoiesis Modulation

Isoindole Derivatives

Carboxypeptidase Z

Nicotinic Acetylcholine Receptor

77 patents: Sort by Forward Citations

1. 8518967 - Amides of acetic and propionic acids (2013-08-27),

2. 8178359 - Masking of the background fluorescence and luminescence in the optical analysis of biomedical assays (2012-05-15),

3. 8030347 - Cylopenta[b]benzofuran derivatives and the utilization thereof (2011-10-04),

4. 7687510 - Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes (2010-03-30),

5. 7566723 - 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use (2009-07-28),

6. 7553851 - Amides of acetic and propionic acids (2009-06-30),

7. 7544709 - Derivatives of andrimide and moiramide B having antibacterial properties (2009-06-09),

8. 7498460 - Isophthalic acid derivatives (2009-03-03),

9. 7491550 - Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) (2009-02-17),

10. 7482472 - Substituted isoindoles and their use (2009-01-27),

11. 7476319 - Method and apparatus for continuously controlling denitrification in variable nitrogen loads in wastewater (2009-01-13),

12. 7465548 - Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a (2008-12-16),

13. 7449198 - Stable salts of O-acetylsalicylic acid with basic amino acids (2008-11-11),

14. 7427617 - Morpoline-bridged indazole derivatives (2008-09-23),

15. 7423175 - Hydroxy-tetrahydro-naphthalenylurea derivatives (2008-09-09),

Bayer Healthcare Aktiengesellschaft is a leading pharmaceutical and life sciences company that specializes in developing innovative medicines and products to improve human and animal health. With a strong focus on research and development, Bayer Healthcare is committed to making a positive impact on the well-being of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

77 Patents

#7 in Leverkusen

#781 in Germany

#9,511 in the World

Leverkusen, Germany

Bayer Healthcare Aktiengesellschaft

Forward Citations = 656

241 inventors:

Karl-Heinz Schlemmer (14 out of 120 patents)

Thomas Lampe (10 out of 42 patents)

Joachim Luithle (9 out of 32 patents)

4. Jörg Keldenich (9 out of 41 patents)

5. Johannes-Peter Stasch (8 out of 150 patents)

Please report any incorrect information to support@idiyas.com

Loading…